1-10 of 10
Cécile Bonnafous
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preclinical Characterization of Antitumor Activity of IPH6501, a First-in-Class IL2v-Armed Tetraspecific NK Cell Engager Directed Against CD20, and Comparison with Approved CD20-Targeting Therapies

Florent Carrette, Olivier Demaria, William Baron, Marilyn Giordano, Nourhène Belaid, Jean-Baptiste Vallier, Sylvia Trichard, Manon Clemenceau, Mathilde Girard-Madoux, Marie Vétizou, Romain Remark, Marie-Laure Thibult, Caroline Denis, Pascale Andre, Cécile Bonnafous, Ariane Morel, Nicola Beltraminelli, Yannis Morel, Carine Paturel, Eric Vivier
Journal: Blood
Blood (2024) 144 (Supplement 1): 5824.
https://doi.org/10.1182/blood-2024-201502
Published: 2024
Journal Articles

Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial

Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Martine Bagot, Youn-H H. Kim, Larisa J Geskin, Pablo L Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Lubomir Sokol, Marie Beylot-Barry, Stéphane Dalle, Eric D. Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S. Khodadoust, Pier Luigi Zinzani, Julien Viotti, David Magrez, Agnes Boyer Chammard, Constance Vagne, Flavien Carraguel, Laura Assante Miranda, Valentine Peri, Sivan Bokobza, Marie-Laure Thibult, Cécile Bonnafous, Florent Carrette, Pierluigi Porcu
Journal: Blood
Blood (2024) 144 (Supplement 1): 1609.
https://doi.org/10.1182/blood-2024-200587
Published: 2024
Journal Articles

KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target

Morgane Cheminant, Ludovic Lhermitte, Julie Bruneau, Hélène Sicard, Cécile Bonnafous, Aurore Touzart, Estelle Bourbon, Nicolas Ortonne, Laurent Genestier, Philippe Gaulard, Patricia Palmic, Felipe Suarez, Laurent Frenzel, Louise Naveau, Ali Bazarbachi, Mickaël Dussiot, Laetitia Waast, Véronique Avettand-Fenoel, Chantal Brouzes, Claudine Pique, Yves Lepelletier, Vahid Asnafi, Ambroise Marçais, Olivier Hermine
Journal: Blood
Blood (2022) 140 (13): 1522–1532.
https://doi.org/10.1182/blood.2022016765
Published: 2022
Includes: Supplemental data
Journal Articles

KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting

Maxime Battistella, Christophe Leboeuf, Caroline Ram-Wolff, Charlotte Hurabielle, Cécile Bonnafous, Hélène Sicard, Armand Bensussan, Martine Bagot, Anne Janin
Journal: Blood
Blood (2017) 130 (26): 2900–2902.
https://doi.org/10.1182/blood-2017-06-792382
Published: 2017
Includes: Supplemental data
Journal Articles

First-in-Human, Multicenter Phase I Study of IPH4102, First-in-Class Humanized Anti-KIR3DL2 Monoclonal Antibody, in Relapsed/Refractory Cutaneous T-Cell Lymphomas: Preliminary Safety, Exploratory and Clinical Activity Results

Martine Bagot, MD, Pierluigi Porcu, MD, Caroline Ram-Wolff, MD, Michael Khodadoust, MD PhD, Maxime Battistella, MD, Anne Marie-Cardine, PhD, Steve Mathieu, MD, Maarten H. Vermeer, MD PhD, Sean Whittaker, MB, ChB, FRCP, MD, Madeleine Duvic, MD, Armand Bensussan, PhD, Carine Paturel, PhD, Cecile Bonnafous, PhD, Nicolas Thonnart, Agnes Widemann, PharmD, Cecile Bonin, PharmD, Helene Sicard, PhD, Christine Paiva, Korinna Pilz, MD, Youn Kim, MD
Journal: Blood
Blood (2016) 128 (22): 1826.
https://doi.org/10.1182/blood.V128.22.1826.1826
Published: 2016
Journal Articles

Lirilumab Enhances Anti-Tumor Efficacy of Elotuzumab

Caroline Sola, PhD, Mathieu Blery, PhD, Cécile Bonnafous, PhD, Elodie Bonnet, Nicolas Fuseri, Robert F Graziano, PhD, Yannis Morel, PhD, Pascale André, PhD
Journal: Blood
Blood (2014) 124 (21): 4711.
https://doi.org/10.1182/blood.V124.21.4711.4711
Published: 2014
Journal Articles

Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies

Holbrook E. Kohrt, Ariane Thielens, Aurelien Marabelle, Idit Sagiv-Barfi, Caroline Sola, Fabien Chanuc, Nicolas Fuseri, Cécile Bonnafous, Debra Czerwinski, Amanda Rajapaksa, Erin Waller, Sophie Ugolini, Eric Vivier, François Romagné, Ronald Levy, Mathieu Bléry, Pascale André
Journal: Blood
Blood (2014) 123 (5): 678–686.
https://doi.org/10.1182/blood-2013-08-519199
Published: 2014
Includes: Supplemental data
Journal Articles

Anti-KIR Antibody Enhancement Of Anti-Lymphoma Activity Of Natural Killer Cells As Monotherapy and In Combination With Anti-CD20 Antibodies

Holbrook E Kohrt, MD, PhD, Ariane Thielens, Aurelien Marabelle, MD, MSc, Idit Sagiv Barfi, Caroline Sola, Fabien Chanuc, Nicolas Fuseri, Cécile Bonnafous, Debra K Czerwinski, Amanda Rajapaksa, Erin Waller, Sophie Ugolini, PhD, Eric Vivier, PhD, Francois Romagne, PhD, Ronald Levy, MD, Pascale Andre, PhD, Mathieu Blery, PhD
Journal: Blood
Blood (2013) 122 (21): 4417.
https://doi.org/10.1182/blood.V122.21.4417.4417
Published: 2013
Journal Articles

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Brief Report
Don M. Benson, Jr, Courtney E. Bakan, Shuhong Zhang, Shauna M. Collins, Jing Liang, Shivani Srivastava, Craig C. Hofmeister, Yvonne Efebera, Pascale Andre, Francois Romagne, Mathieu Bléry, Cécile Bonnafous, Jianying Zhang, David Clever, Michael A. Caligiuri, Sherif S. Farag
Journal: Blood
Blood (2011) 118 (24): 6387–6391.
https://doi.org/10.1182/blood-2011-06-360255
Published: 2011
Includes: Supplemental data
Journal Articles

Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies

Julie Gertner-Dardenne, Cecile Bonnafous, Christine Bezombes, Aude-Hélène Capietto, Virginie Scaglione, Sophie Ingoure, Delphine Cendron, Emilie Gross, Jean-François Lepage, Anne Quillet-Mary, Loîc Ysebaert, Guy Laurent, Hélène Sicard, Jean-Jacques Fournié
Journal: Blood
Blood (2009) 113 (20): 4875–4884.
https://doi.org/10.1182/blood-2008-08-172296
Published: 2009
Includes: Supplemental data